State Of Wyoming Vir Biotechnology, Inc. Transaction History

State Of Wyoming

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.6 - $11.9 $1,444 - $1,999	168 Added 2.07%	8,287 $83,000
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $41,065 - $54,454	5,292 Added 187.19%	8,119 $81,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $24,851 - $66,941	2,719 Added 2517.59%	2,827 $26,000
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $171,633 - $201,891	-7,398 Reduced 98.56%	108 $2,000
Q1 2023 May 12, 2023	SELL	$22.26 - $30.85 $54,648 - $75,736	-2,455 Reduced 24.65%	7,506 $174,000
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $97,963 - $138,503	4,908 Added 97.13%	9,961 $252,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $42,290 - $72,027	2,316 Added 84.62%	5,053 $97,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $52,221 - $73,077	2,737 New	2,737 $70,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.